Designated benefit for the satisfaction of basic needs as a form of preventing social isolation
Social Entrepreneurship Review · 23.02.2026 · 1 · 35-47
DOI: 10.15678/es.2020.1.04 ↗Kurz gefasst
Fachartikel in der Zeitschrift Social Entrepreneurship Review, online erschienen am 23.02.2026. Verfasst von Katarzyna Małysa-Sulińska und 1 weiteren Autor:innen. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The purpose of social service is to support the individual, and thus counteracting social isolation. Normative regulations in this regard are covered by the law of social service from the 12th of March 2004, which determines the types of benefits and the rules of impartment. One of those benefits is the designated benefit for basic needs. In the article, the ponderation has been done about if the designated benefit is a successful tool against social isolation. Thereupon, the normative regulations which determine the appropriation and form of this benefit have been analyzed and presented. This analysis concludes that the institution of the designated benefit for basic needs, which functions in the Polish legal system, could be perceived as an effective mechanism that counteracts social isolation.
Zitieren
APA
Małysa-Sulińska, K., & Kawecka, A. (2026). Designated benefit for the satisfaction of basic needs as a form of preventing social isolation. Social Entrepreneurship Review, 1, 35-47. https://doi.org/10.15678/es.2020.1.04
Vancouver
Małysa-Sulińska K, Kawecka A. Designated benefit for the satisfaction of basic needs as a form of preventing social isolation. Social Entrepreneurship Review. 2026;1:35-47. doi:10.15678/es.2020.1.04
BibTeX
@article{MaysaSuliska2026,
author = {Małysa-Sulińska, Katarzyna and Kawecka, Anna},
title = {Designated benefit for the satisfaction of basic needs as a form of preventing social isolation},
journal = {Social Entrepreneurship Review},
year = {2026},
volume = {1},
pages = {35--47},
doi = {10.15678/es.2020.1.04}
}
EUVIMED